RecruitingNot ApplicableNCT06690892

Investigating the Effects of Beef Consumption on Cognitive and Brain Health

Understanding the Cognitive and Brain Health Effects of Increasing Beef Consumption in Young Adults


Sponsor

University of Nebraska Lincoln

Enrollment

240 participants

Start Date

Sep 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if eating more beef will lead to better cognition and a healthier brain in younger adults. The main questions it aims to answer are: * Does eating more beef lead to higher scores on cognitive tests and better quality of life? * Does eating more beef lead to better brain function? Researchers will compare participants in the experimental group (participants who will eat 25 ounces of beef every week during the dietary intervention) to control participants (participants who will eat 5 ounces of beef every week during the dietary intervention). Participants will: * Be instructed to prepare and consume ready-to-eat beef meals along with their regular diet and not eat any more beef other than what they are given * Visit the study facilities once every week to pick up ready-to-eat beef meals; and complete a brief survey every week to track their consumption of the provided beef meals, and a dietary survey every 4 weeks * Visit the study facilities before and after the 12-week of intervention period for researchers to study them


Eligibility

Min Age: 19 YearsMax Age: 24 Years

Inclusion Criteria11

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
  • Males and females; Age 19-24
  • Willingness to adhere to the ready-to-eat beef intervention regimen
  • Enrolled at University of Nebraska-Lincoln
  • BMI between 18.5 and 39.9
  • Not pregnant or nursing
  • No history of cognitive or metabolic diseases indicated by diagnosis, including neurodegenerative disease, stroke, Type 1 and 2 diabetes, metabolic syndrome, cardiovascular disease, liver disease, kidney disease, and cancer
  • No history of eating or anxiety disorders
  • Willing to discontinue dietary supplement use throughout the duration of the study, if they are consuming supplement at the time of the registration
  • No known contraindication to MRI scans as determined by the MRI screening survey questions

Exclusion Criteria4

  • Current use of medications that may affect their responses to dietary intervention, such as amphetamines, antidepressants, anti-diabetic medications, laxatives, antibiotics, statins and diuretics.
  • Known intolerance or allergy to beef
  • Current use of nicotine products, including vaping
  • Previous use of nicotine products, including vaping, within the recent 6 months at the time of pre-screening

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTReady-to-eat beef in frozen, 5-oz packages

The dietary intervention lasts 12 weeks for each individual. Participants in the experimental group will receive this intervention. Each participant will acquire 5 portions of ready-to eat beef in frozen packages per week, and consume 5 portions per week (1 portion of sirloin cap steak strips, 1 portion of shredded chuck roast, 1 portion of petite shoulder medallions, and 2 portions of ground beef crumbles); each portion of ready-to-eat beef in this intervention will weigh 5 ounces.

DIETARY_SUPPLEMENTReady-to-eat beef in frozen, 1-oz packages

The dietary intervention lasts 12 weeks for each individual. Participants in the control group will receive this intervention. Each participant will acquire 5 portions of ready-to eat beef in frozen packages per week, and consume 5 portions per week (1 portion of sirloin cap steak strips, 1 portion of shredded chuck roast, 1 portion of petite shoulder medallions, and 2 portions of ground beef crumbles); each portion of ready-to-eat beef in this intervention will weigh 1 ounce.


Locations(1)

University of Nebraska-Lincoln

Lincoln, Nebraska, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06690892


Related Trials